WNK2 and metabolic disease: Recent studies have highlighted their involvement in multiple signaling pathways such as mitogen-activated protein kinase, Jun N-terminal kinase and Hippo, implicating them in conditions such as cancer, autoimmune and metabolic disorders and neurodegenerative diseases.